Conclusions -An association between HLA and sarcoidosis was noted at the DNA level, although no restriction fragments were specific for this disease. RFLP analysis of the HLA gene is a more useful method than the usual HLA typing, and should be the first step in identifying the gene sequence which is connected with susceptibility to sarcoidosis. (Thorax 1994;49:573-576) Sarcoidosis is a systemic granulomatous disease with frequent respiratory symptoms and changes on the chest radiograph. The pathogenesis of sarcoidosis remains unclear, but some studies suggest that it is an immunological disorder. In order to investigate the immunogenetic mechanisms the HLA system has frequently been examined.
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We have previously found a significant association with HLA-DRw52 antigen in Japanese patients with sarcoidosis,' the first such finding in any ethnic group. After our report associations with HLA-DRw8, as well as with DRw52, were also found in Japanese patients by others.2 In a German population an association between sarcoidosis and HLA-DR5 was reported.3 Findings from these three studies seemed to be similar because HLA-DRw52 is in strong linkage disequilibrium with DR5 and DRw8. It has not been possible, however, by conventional serological methods, to determine which HLA antigen plays the most important part in the pathogenesis of sarcoidosis.
Associations between HLA and many other diseases are currently being analysed with molecular biological techniques. HLA is highly polymorphic at the DNA level and restriction fragment length polymorphism (RFLP) 
Results

HLA ANTIGEN FREQUENCIES IN PATIENTS WITH SARCOIDOSIS
The frequencies of HLA-D region antigens in a group of 32 patients with sarcoidosis and 47 control subjects are given in table 1. The frequency of HLA-DRw52 was 75-0% in the patient group and 51 1% in the control group and this difference was statistically significant (X2=458, p<005). Among HLA-A, B, C, and HLA-DQ antigens there was no antigen whose frequency showed a significant difference between the patients and the control subjects (data not shown for HLA-A, B, and C antigens).
RFLP ANALYSIS FOR THE HLA-DRI GENE
RFLP analysis was performed in the 32 patients with sarcoidosis and the 47 control subjects. Restriction fragments of 24 DRw52 positive patients, hybridised with a DR,B probe after digestion with Eco RI, are shown in the figure. The RFLP analysis could detect polymorphism which was not distinguishable by usual HLA typing -for example, under digestion with Eco RI five DRw52 positive patients serologically typed as DR4 and DRw8 showed four different patterns of RFLP.
The frequencies of restriction fragments of the DRI3 gene, after digestion with Eco RI, Pst I, Bam HI, Pvu II, and Hind III, are summarised in table 2. Only restriction fragments whose frequencies were statistically different between the patients and the controls are shown. There were five DRI3 fragments whose frequencies were higher in the patients than in the controls; Eco RI 10 kb, Eco RI 4 6 kb, Pst I 52kb, Bam HI 11kb, and Pvu II 95kb fragments. All these were only seen in DRw52 positive individuals except for Pst I 52 kb In order to analyse whether there were different clinical features between the patients with and without the five restriction fragments the patients were divided into two groups according to the presence of the fragments. Group 1 consisted of patients who had three or more of the five fragments and group 2 consisted of patients with up to two fragments. The correlation between groups 1 and 2 and various clinical features or other organ involvement is summarised in table 3. There were more patients in group 1 than in group 2 whose clinical stage was limited to stage I (p < 0.05). With regard to involvement of other organs, there were more patients in group 1 than in group 2 without an ophthalmic disorder (p < 005). HLA-D region antigens are composed of at least three different groups of antigen molecules -DR, DQ, and DP antigens'9 -but an association with sarcoidosis has so far been reported only with DR antigens. The HLA-DR antigens in which an association with sarcoidosis has been reported are DRw52,12 DRw8,2 and DRw92 in Japanese subjects, DR5 in Germans,3 and DR7 in West Indians.20 Among these antigens an association with DRw52, DR5, or DRw8 which was reported by three groups including ours is reproducible and the most interesting because DRw52 is in strong linkage disequilibrium with DR5 and DRw8. In this study frequencies of most HLA-DR antigens were similar to those found in our previous study.' The largest difference was observed in the frequency of DRw53 in the patients between the two studies, but this difference was not statistically significant. The association with DRw52, which we previously reported, was also observed in the present study. It should be concluded that DRw52 antigen occurs in 70-80% of Japanese patients with sarcoidosis, but only in 50-55% of healthy controls. It was also noted that DR5 and DRw8 antigens were more common in patients with sarcoidosis than in controls, but an association with DRw9 was not observed. DR7 is a very rare antigen in the Japanese population2' and there were no patients with DR7 in this study. 
